UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Annals of oncology, 2020-07, Vol.31 (7), p.942-950

2020

Volltextzugriff (PDF)

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

Annals of oncology, 2022-04, Vol.33 (4), p.406-415

2022

Volltextzugriff (PDF)

Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study

Annals of oncology, 2018-08, Vol.29 (8), p.1807-1813

2018

Volltextzugriff (PDF)

Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor

Annals of oncology, 2015-02, Vol.26 (2), p.348-354

2015

Volltextzugriff (PDF)

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma

Annals of oncology, 2017-04, Vol.28 (4), p.890-897

2017

Volltextzugriff (PDF)

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

Annals of oncology, 2017-02, Vol.28 (2), p.292-297

2017

Volltextzugriff (PDF)

Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults

Annals of oncology, 2014-11, Vol.25 (11), p.2260-2266

2014

Volltextzugriff (PDF)

A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma

Annals of oncology, 2017-11, Vol.28 (11), p.2754-2760

2017

Volltextzugriff (PDF)

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

Annals of oncology, 2013-08, Vol.24 (8), p.2080-2087

2013

Volltextzugriff (PDF)

Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

ESMO open, 2021-12, Vol.6 (6), p.100309, Article 100309

2021

Volltextzugriff (PDF)

Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study

ESMO open, 2023-04, Vol.8 (2), p.100877-100877, Article 100877

2023

Volltextzugriff (PDF)

Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18

ESMO open, 2023-08, Vol.8 (4), p.101588, Article 101588

2023

Volltextzugriff (PDF)

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2015-11, Vol.373 (19), p.1814-1823

2015

Volltextzugriff (PDF)

Seaweed processing using industrial single-mode cavity microwave heating: a preliminary investigation

Carbohydrate research, 2005-05, Vol.340 (7), p.1357-1364

2005

Volltextzugriff (PDF)

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

The New England journal of medicine, 2023-11, Vol.389 (20), p.1851-1861

2023

Volltextzugriff (PDF)

Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients

Journal of viral hepatitis, 2009-06, Vol.16 (6), p.444-452

2009

Volltextzugriff (PDF)

Aggressiveness of Cancer-Care near the End-of-Life in Korea

Japanese journal of clinical oncology, 2008-05, Vol.38 (5), p.381-386

2008

Volltextzugriff (PDF)

Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments

Nature communications, 2023-05, Vol.14 (1), p.2697-2697, Article 2697

2023

Volltextzugriff (PDF)

Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss

Cell death & disease, 2022-09, Vol.13 (9), p.777-17, Article 777

2022

Volltextzugriff (PDF)

Lanreotide Autogel®: A Review of its Use in the Treatment of Patients with Acromegaly

Drugs (New York, N.Y.), 2014-09, Vol.74 (14), p.1673-1691

2014

Volltextzugriff (PDF)

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

The Journal of clinical investigation, 2021-11, Vol.131 (22), p.1-15

2021

Volltextzugriff (PDF)

Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells

Molecular & cellular proteomics, 2018-06, Vol.17 (6), p.1170-1183

2018

Volltextzugriff (PDF)

Toxicity in the era of immune checkpoint inhibitor therapy

Frontiers in immunology, 2024, Vol.15, p.1447021

2024

Volltextzugriff (PDF)

Selexipag: A Review in Pulmonary Arterial Hypertension

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2017-02, Vol.17 (1), p.73-80

2017

Volltextzugriff (PDF)

Results of the 2005-2008 Association of Residents in Radiation Oncology Survey of Chief Residents in the United States: Clinical Training and Resident Working Conditions

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.1120-1127

2011

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Humans
(30)
Life Sciences & Biomedicine
(30)
Male
(17)
Oncology
(17)
Female
(13)
Middle Aged
(12)
Adult
(10)
Aged
(10)
Aged, 80 And Over
(7)
Mutation
(7)
Tumors
(7)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Antineoplastic Agents - Therapeutic Use
(5)
Cancer
(5)
Animals
(4)
Disease-Free Survival
(4)
Patients
(4)
Quinazolines - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study

Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults

A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study

Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

Seaweed processing using industrial single-mode cavity microwave heating: a preliminary investigation

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients

Aggressiveness of Cancer-Care near the End-of-Life in Korea

Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments

Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss

Lanreotide Autogel®: A Review of its Use in the Treatment of Patients with Acromegaly

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells

Toxicity in the era of immune checkpoint inhibitor therapy

Selexipag: A Review in Pulmonary Arterial Hypertension

Results of the 2005-2008 Association of Residents in Radiation Oncology Survey of Chief Residents in the United States: Clinical Training and Resident Working Conditions

Aktive Filter

Suchergebnisse filtern